The DOI matches its Crossref record; 96 of the 101 references it cites were found in a registry or an index; 33 of the 53 sources its claims cite were checked for support.
Role of Omega-3 Fatty Acids in Improving Metabolic Dysfunctions in Polycystic Ovary Syndrome
Open accessAbstract
Polycystic ovary syndrome (PCOS) is a common endocrine disorder that impacts women of reproductive age. In addition to reproductive and psychological complications, women with PCOS are also at a higher risk of developing metabolic diseases such as obesity, type 2 diabetes and cardiovascular disease. While weight reduction can help manage these complications in overweight or obese women, many weight loss interventions have been ineffective due to weight stigma and its psychological impact on women with PCOS. Therefore, exploring alternative dietary strategies which do not focus on weight loss per se is of importance. In this regard, omega-3 polyunsaturated fatty acids of marine origin (n-3 PUFAs), which are known for their hypotriglyceridemic, cardioprotective and anti-inflammatory effects, have emerged as a potential therapy for prevention and reversal of metabolic complications in PCOS. Several clinical trials showed that n-3 PUFAs can improve components of metabolic syndrome in women with PCOS. In this review, we first summarize the available clinical evidence for different dietary patterns in improving PCOS complications. Next, we summarize the clinical evidence for n-3 PUFAs for alleviating metabolic complications in PCOS. Finally, we explore the mechanisms by which n-3 PUFAs improve the metabolic disorders in PCOS in depth.
Overview
CoChat Summary
TL;DR
This is a narrative review arguing that omega-3 polyunsaturated fatty acids, especially marine EPA and DHA, may help improve metabolic dysfunction in PCOS. The paper concludes that n-3 PUFAs can reduce triglycerides, improve insulin resistance, and lower inflammation, but says mechanistic evidence is still limited.
Key findings
- In a meta-analysis of 9 randomized controlled studies (591 women with PCOS), n-3 PUFA supplementation decreased HOMA-IR, total cholesterol, and triglycerides; triglycerides fell by a mean of 29.21 mg/dl (95% CI −48.08, −10.34).
- Another meta-analysis of 11 randomized controlled trials (816 women with PCOS) found beneficial effects of n-3 PUFAs, especially in trials longer than 8 weeks, on HOMA-IR, triglycerides, cholesterol, and adiponectin.
- A meta-analysis of 10 randomized clinical trials reported that n-3 PUFA supplementation decreased hs-CRP and increased adiponectin in women with PCOS.
- In a meta-analysis of 10 randomized controlled trials (610 patients), n-3 PUFA decreased total testosterone and increased SHBG; a cited randomized cross-over study found that 2.4 g/day EPA + DHA for 6 weeks significantly reduced bioavailable testosterone.
Methods
- Narrative review of PCOS diagnosis, pathophysiology, dietary patterns, and the clinical/mechanistic literature on n-3 PUFAs.
- Synthesizes evidence from clinical trials, meta-analyses, cross-sectional/case-control studies, and animal studies; no original participant sample was recruited by this paper.
- Main analysis is qualitative synthesis of reported effects and proposed mechanisms, with specific trial and meta-analysis results summarized in the text.
Limitations
- The paper states that only a few mechanistic studies are available to explain how n-3 PUFAs improve PCOS-related outcomes.
- The paper states that the mechanisms by which n-3 PUFAs reduce androgen production and increase SHBG in PCOS warrant further research.
- Evident from the text: this is a narrative review, so it does not present a new pooled meta-analysis or original dataset of its own.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
28 Valid · 1 Not valid · 12 Not checked · 5 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“In a case-control study, the PREDIMED score (indicative of the degree of adherence to this dietary pattern) showed a negative correlation with serum testosterone [41]”
§ Role of Omega-3 Fatty Acids in Improving Metabolic Dysfunctions in Polycystic Ovary Syndrome > 3. Dietary Patterns for Preventing/Treating Metabolic Complications of PCOS > 3.1. Mediterranean Diet
What the sources say
- Supportedcites [41] Barrea, L., Arnone, A., Annunziata, G., Muscogiuri, G., Laudisio, D., Salzano, C., Pugliese, G., Colao, A., and Savastano, S. (2019). Adherence to the Mediterranean Diet, Dietary Patterns and Body Composition in Women with Polycystic Ovary Syndrome (PCOS). Nutrients, 11. source
The Results (Correlation Studies) report a significant negative correlation between PREDIMED score and testosterone levels in women with PCOS after adjustment for BMI and total energy intake. The Results also identify the study groups as 112 PCOS cases and 112 controls. (LLM, conf=0.94)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Another meta-analysis of 19 trials comprising 1193 participants confirmed that the DASH diet was superior to other eating patterns in improving insulin resistance in women with PCOS [45].”
§ Role of Omega-3 Fatty Acids in Improving Metabolic Dysfunctions in Polycystic Ovary Syndrome > 3. Dietary Patterns for Preventing/Treating Metabolic Complications of PCOS > 3.2. DASH Diet
What the sources say
- Partly supportedcites [45] Shang, 2020, Effect of Diet on Insulin Resistance in Polycystic Ovary Syndrome, J. Clin. Endocrinol. Metab. sourceExperimental — accuracy not yet measured
The Study selection and characteristics section reports 19 trials involving 1,193 women with PCOS. The HOMA-IR results say a subgroup analysis found greater benefit from DASH than from a low-carbohydrate diet, but do not establish superiority over all other eating patterns. The Discussion says DASH only “seemed” more effective, and the Conclusion cautions that more trials are needed; neither presents the finding as confirmed. Page numbers were not available in the supplied passages. (LLM, conf=0.88)
boostedstates a causen = 1,193- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“A Cochrane database systematic review including 498 participants from 15 randomized controlled trials showed that lifestyle modification can decrease the free androgen index and body mass index in women with PCOS [33].”
§ Role of Omega-3 Fatty Acids in Improving Metabolic Dysfunctions in Polycystic Ovary Syndrome > 2. PCOS—Diagnosis, Pathophysiology and Management > 2.3. Outline of the Management of PCOS
What the sources say
- Supportedcites [33] Lim, 2019, Lifestyle Changes in Women with Polycystic Ovary Syndrome, Cochrane Database Syst. Rev. source
The Main results section reports 15 studies with 498 participants and says lifestyle intervention may improve free androgen index and reduce BMI in women with PCOS. The Results of the search section identifies the included studies as randomized controlled trials. The 498 participants are the review total, not the number contributing to each outcome analysis. (LLM, conf=0.94)
plainstates a causen = 498- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Several clinical studies have demonstrated that n-3 PUFAs can indeed improve various components of the metabolic syndrome, including dyslipidemia, inflammation and insulin resistance in women with PCOS [13].”
§ Role of Omega-3 Fatty Acids in Improving Metabolic Dysfunctions in Polycystic Ovary Syndrome > 1. Introduction
What the sources say
- Partly supportedcites [13] Yang, K., Zeng, L., Bao, T., and Ge, J. (2018). Effectiveness of Omega-3 Fatty Acid for Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis. Reprod. Biol. Endocrinol., 16. sourceExperimental — accuracy not yet measured
The Background reports newer RCTs with beneficial effects on insulin resistance and serum lipids in women with PCOS. The Discussions also describe reduced inflammation, but characterize the meta-analysis findings as effects omega-3 fatty acids *may* have and caution that the trials were small. Saying the studies have demonstrated improvement overstates that uncertainty. (LLM, conf=0.86)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“In a systematic review of 19 randomized controlled trials including 727 patients with PCOS, the DASH diet was identified as the most effective eating pattern in reducing Homeostatic Model Assessment for Insulin Resistance (HOMA-IR; a marker of insulin resistance) and serum triglycerides [44].”
§ Role of Omega-3 Fatty Acids in Improving Metabolic Dysfunctions in Polycystic Ovary Syndrome > 3. Dietary Patterns for Preventing/Treating Metabolic Complications of PCOS > 3.2. DASH Diet
What the sources say
- Supportedcites [44] Stubnya, 2024, Ranking the Dietary Interventions by Their Effectiveness in the Management of Polycystic Ovary Syndrome: A Systematic Review and Network Meta-Analysis, Reprod. Health source
The Abstract’s Results section reports 19 RCTs comprising 727 patients and ranks the DASH diet as most effective for reducing both HOMA-IR and triglyceride levels. The Discussion gives a different patient count (708), but the claimed count is explicitly stated in the Abstract. (LLM, conf=0.95)
plainstates a causen = 727- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
18 more claims · 9 with their cited sources checked
Create a free account to see all 46 claims and to verify the 7 references still open.
- It may state two separate claims as one. 22
- Probably not a substantial claim. 2
Citations
Cites
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
Bhatt, D. L., Steg, P. G., Miller, M., Brinton, E. A., Jacobson, T. A., Ketchum, S. B., Doyle, R. T., Juliano, R. A., Jiao, L., Granowitz, C., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1812792 · Cited by 3,317 · cited 1×
“…ester (icosapent ethyl—4 g/day) reduced major cardiovascular events in patients with existing cardiovascular disease or diabetes and elevated plasma triglycerides [81], confirming that the triglyceride-lowering effects of these fatty acids also extend into cardio-protection in the longer term.”
BackgroundOh, D. Y., Talukdar, S., Bae, E. J., Imamura, T., Morinaga, H., Fan, W., Li, P., Lu, W. J., Watkins, S. M., & Olefsky, J. M. (2010) · Cell · doi:10.1016/j.cell.2010.07.041 · Cited by 2,428 · cited 1×
“Further, EPA/DHA are potent activators of the G protein-coupled receptor 120 (GPR120), which has potent anti-inflammatory effects, particularly against macrophage-induced tissue inflammation [92].”
Azziz, R., Carmina, E., Chen, Z., Dunaif, A., Laven, J. S. E., Legro, R. S., Lizneva, D., Natterson-Horowtiz, B., Teede, H. J., & Yildiz, B. O. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.57 · Cited by 2,005 · cited 2×
“An intricate interplay between neuroendocrine disruptions and insulin resistance is likely responsible for the heterogeneity of PCOS presentation Previous reviews have discussed these mechanisms in detail [3,14] and a brief outline is provided below and illustrated in Figure 1. women.”
BackgroundOmega-3 fatty acids EPA and DHA: Health benefits throughout life
Swanson, D., Block, R., & Mousa, S. A. (2012) · Advances in Nutrition · doi:10.3945/an.111.000893 · Cited by 1,575 · cited 1×
“For example, the anti-inflammatory, hypotriglyceri-demic, and cardioprotective effects of n -3 PUFA have been mainly demonstrated for EPA and DHA [61].”
BackgroundCriteria, Prevalence, and Phenotypes of Polycystic Ovary Syndrome
Lizneva, D., Suturina, L., Walker, W., Brakta, S., Gavrilova-Jordan, L., & Azziz, R. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.05.003 · Cited by 1,358 · cited 1×
“Polycystic ovary syndrome (PCOS) is the most common endocrine disorder among women of reproductive age with a prevalence ranging from 4 to 21% depending on the diagnostic criteria used [1].”
BackgroundResolvins in inflammation: emergence of the pro-resolving superfamily of mediators
Serhan, C. N., & Levy, B. D. (2018) · Journal of Clinical Investigation · doi:10.1172/jci97943 · Cited by 1,344 · cited 1×
“Resolvins, protectins, and maresins are EPA/DHA-derived SPMs, which enhance the resolution phase of inflammation [88].”
BackgroundThe Opposing Effects of N-3 and n-6 Fatty Acids
Schmitz, G., & Ecker, J. (2008) · Progress in Lipid Research · doi:10.1016/j.plipres.2007.12.004 · Cited by 1,245 · cited 1×
“Both classes are considered essential fatty acids because the human body cannot synthesize sufficient amounts of these fatty acids de novo [55].”
BackgroundDistribution, interconversion, and dose response of n-3 fatty acids in humans.
Arterburn, L. M., Hall, E. B., & Oken, H. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.6.1467s · Cited by 1,162 · cited 2×
“Further, while LA can be converted to AA and ALA can be converted to EPA and then DHA, respectively, this conversion is inefficient in humans [59] and is unlikely to lead to high AA and EPA/DHA levels in the body.”
BackgroundThe role of hepatic lipids in hepatic insulin resistance and type 2 diabetes
Perry, R. J., Samuel, V. T., Petersen, K. F., & Shulman, G. I. (2014) · Nature · doi:10.1038/nature13478 · Cited by 1,136 · cited 1×
“Obesity also gives rise to ectopic lipid deposition in the liver and skeletal muscle, leading to lipotoxicity, which in turn can lead to insulin resistance [22].”
BackgroundDinu, M., Pagliai, G., Casini, A., & Sofi, F. (2018) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2017.58 · Cited by 1,016
Cited by
The Role of Lifestyle Interventions in PCOS Management: A Systematic Review
Gautam, R., Maan, P., Jyoti, A., Kumar, A., Malhotra, N., & Arora, T. (2025) · Nutrients · doi:10.3390/nu17020310 · Cited by 115
“Omega-3 fatty acids have powerful anti-inflammatory properties that can improve insulin sensitivity and decrease androgen levels in metabolic syndromes like PCOS [121].”
Merza, W. M., Yaseen, A. K., & Mahmood, M. A. (2025) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2025.106773 · Cited by 27
Gautam, R., Bhateja, A., Malhotra, N., & Arora, T. K. (2025) · Clinical Epidemiology and Global Health · doi:10.1016/j.cegh.2025.102024 · Cited by 9
Tarantino, G., & Citro, V. (2026) · World Journal of Gastroenterology · doi:10.3748/wjg.119467 · Cited by 19
Sangeetha, A. L., & Geetha, P. (2024) · International Conference on Data Intelligence and Cognitive Informatics (ICDICI) · doi:10.1109/icdici62993.2024.10810804 · Cited by 5
Metadata
- Authors
- Albardan, L., Platat, C., & Kalupahana, N. S.
- Affiliations
- United Arab Emirates University (AE)
- Corresponding author
- Kalupahana, Nishan Sudheera
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2024-09-03
- Volume
- 16
- Issue
- 17
- Pages
- 2961
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC11397015
- OpenAlex
- W4402198951
- Cited by
- 18
- References
- 101
- Citations by year
- 2026: 6 · 2025: 9 · 2024: 3
- FWCI
- 1.26
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- United Arab Emirates University (G00004624)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Keywords
- polycystic ovary syndrome, omega-3 fatty acids, metabolic dysfunction, metabolic syndrome, obesity, type 2 diabetes, cardiovascular disease, dietary intervention, weight stigma, anti-inflammatory activity, hypotriglyceridemic effect, cardioprotection
- MeSH terms
- Female, Humans, Obesity, Polycystic Ovary Syndrome, Fatty Acids, Omega-3, Dietary Supplements, Metabolic Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Role of Omega-3 Fatty Acids in Improving Metabolic Dysfunctions in Polycystic Ovary Syndrome. https://app.cochat.ai/papers/10.3390/nu16172961
- The paper
- Albardan, L., Platat, C., & Kalupahana, N. S. (2024). Role of Omega-3 Fatty Acids in Improving Metabolic Dysfunctions in Polycystic Ovary Syndrome. Nutrients. https://doi.org/10.3390/nu16172961
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

